FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

838469001: Trastuzumab deruxtecan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3897070019 Trastuzumab deruxtecan en Synonym Active Entire term case insensitive SNOMED CT core module
3897071015 Trastuzumab deruxtecan (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab deruxtecan Is a Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Has disposition Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is modification of Trastuzumab false Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing trastuzumab deruxtecan (medicinal product) Has active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Trastuzumab deruxtecan Has active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) Has active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) Has active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has basis of strength substance True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier 1
Trastuzumab deruxtecan 100mg powder for solution for infusion vials Has specific active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) 1 vial Has specific active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan 100mg powder for solution for infusion vials 1 vial Has specific active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier
Enhertu 100mg powder for concentrate for solution for infusion vials (Daiichi Sankyo UK Ltd) Has specific active ingredient True Trastuzumab deruxtecan Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start